Royalty Pharma Acquires Fumapharm AG Assets
The purchase involves treatments for multiple sclerosis and psoriasis. Royalty Pharma announces it has acquired an interest in the earn-out payable to the former shareholders of Fumapharm AG for $761...
View ArticlePerrigo Announces FDA Approval Of Betamethasone Valerate Foam 0.12%
The product, from the company’s partner firm Cobrek Pharmaceuticals Inc., is indicated for treatment of scalp psoriasis.Perrigo Co. announced that its partner, Cobrek Pharmaceuticals, Inc., received...
View ArticlePerrigo Announces Commercial Launch of Betamethasone Valerate Foam
The product is the generic equivalent of Luxiq foam, intended for treatment of scalp psoriasis. The Perrigo Company announced that it has begun commercial shipments of betamethasone valerate foam...
View Article
More Pages to Explore .....